{"title": "Comparative effectiveness of Ayurveda treatment and conventional care in knee osteoarthritis: a randomized controlled trial", "author": "Spoo; Michaela", "url": null, "hostname": null, "description": "Osteoarthritis (OA) is of global relevance with up to 250 million people affected by knee OA [Michaud 2006; OARSI 2016; Bitton 2009; Abramson 2009]. Despite progress in conventional care, patients continue to be affected by disability, and there is a need for further treatment approaches [McAlindon 2014; Hochberg 2012; Griffin 1991]. In South Asia, Ayurveda is commonly used as a treatment approach in knee OA. Ayurveda uses individualized treatments with a multi-modal concept utilizing manual and nutritional therapy, herbal therapy, lifestyle counseling and yoga [Tuffs 2002]. No clinical trial evaluated Ayurveda treatment with such an approach for knee OA prior to this study [Lauche 2016]. The goal was to analyze clinical effectiveness of an Ayurvedic method by example of treatments on patients with knee OA. In this case, a comparison was made of the treatment methods Ayurveda and conventional therapy of knee OA. For this purpose, patients diagnosed with knee OA according to ACR (American College of Rheuma-tology) criteria were included in a \"multicenter, randomized, control\u00acled clinical trial\". Of 151 enrolled patients, 77 received Ayurveda therapy and the remaining 74 were treated by conventional therapy. Every participant received 15 treatments during a period of 12 weeks. The primary outcome was the change on the Western Ontario and McMaster University Osteoarthritis (WOMAC) Index according to the validated German version after 12 weeks. Parameters for the secondary outcome consisted of WOMAC subscales (pain, stiffness, function); validated questionnaires for pain, pain experience, quality of life and mood; numeric rating scales for pain and sleep quality; rescue medication use and safety issues. [Kessler 2018] In summary, the improvements shown in the WOMAC Index from baseline to 12 weeks were greater in the \u201cAyurveda group (mean difference 61.0 [95 % CI: 52.4;69.6]) than in the conventional group (32.0 [95 % CI: 21.4;42.6])\u201d. Moreover, this result was under-lined with a significant between-group \u201cdifference (p<0.001) and a clinically relevant effect size (Cohen\u2019s d 0.68 [95 % CI:0.35;1.01])\u201d. After 12 weeks of treatment, com-parable effects in favor of Ayurveda were detected for a number of secondary outcomes. Furthermore, even 3 and 9 months after the last treatments therapy effects persisted. These findings imply that the treatment of knee OA with a complex Ayurvedic therapy might be superior to a complex conventional OA therapy. However, additional studies are required to examine the extent of the effectiveness and to illuminate further the influence of diverse treatment factors and \"non-specific effects\". [Kessler 2018]", "sitename": null, "date": "2022-03-04", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Osteoarthritis (OA) is of global relevance with up to 250 million people affected by knee OA [Michaud 2006; OARSI 2016; Bitton 2009; Abramson 2009]. Despite progress in conventional care, patients continue to be affected by disability, and there is a need for further treatment approaches [McAlindon 2014; Hochberg 2012; Griffin 1991]. In South Asia, Ayurveda is commonly used as a treatment approach in knee OA. Ayurveda uses individualized treatments with a multi-modal concept utilizing manual and nutritional therapy, herbal therapy, lifestyle counseling and yoga [Tuffs 2002]. No clinical trial evaluated Ayurveda treatment with such an approach for knee OA prior to this study [Lauche 2016]. The goal was to analyze clinical effectiveness of an Ayurvedic method by example of treatments on patients with knee OA. In this case, a comparison was made of the treatment methods Ayurveda and conventional therapy of knee OA. For this purpose, patients diagnosed with knee OA according to ACR (American College of Rheuma-tology) criteria were included in a \"multicenter, randomized, control\u00acled clinical trial\". Of 151 enrolled patients, 77 received Ayurveda therapy and the remaining 74 were treated by conventional therapy. Every participant received 15 treatments during a period of 12 weeks. The primary outcome was the change on the Western Ontario and McMaster University Osteoarthritis (WOMAC) Index according to the validated German version after 12 weeks. Parameters for the secondary outcome consisted of WOMAC subscales (pain, stiffness, function); validated questionnaires for pain, pain experience, quality of life and mood; numeric rating scales for pain and sleep quality; rescue medication use and safety issues. [Kessler 2018] In summary, the improvements shown in the WOMAC Index from baseline to 12 weeks were greater in the \u201cAyurveda group (mean difference 61.0 [95 % CI: 52.4;69.6]) than in the conventional group (32.0 [95 % CI: 21.4;42.6])\u201d. Moreover, this result was under-lined with a significant between-group \u201cdifference (p<0.001) and a clinically relevant effect size (Cohen\u2019s d 0.68 [95 % CI:0.35;1.01])\u201d. After 12 weeks of treatment, com-parable effects in favor of Ayurveda were detected for a number of secondary outcomes. Furthermore, even 3 and 9 months after the last treatments therapy effects persisted. These findings imply that the treatment of knee OA with a complex Ayurvedic therapy might be superior to a complex conventional OA therapy. However, additional studies are required to examine the extent of the effectiveness and to illuminate further the influence of diverse treatment factors and \"non-specific effects\". [Kessler 2018]\nArthrose ist eine Erkrankung von globaler Relevanz. Weltweit leiden \u00fcber 250 Mio. Menschen an Gonarthrose [Michaud 2006; OARSI 2016; Bitton 2009; Abramson 2009]. Trotz Fortschritten in der konservativen Gonarthroseversorgung gibt es Patienten, die im Anschluss der Therapie weiterhin mit Einschr\u00e4nkungen leben m\u00fcssen. Daraus resultiert ein Bedarf an wirkungsvollen, zus\u00e4tzlichen Behandlungsmethoden [McAlindon 2014; Hochberg 2012; Griffin 1991]. In S\u00fcdasien ist die traditionelle ayurvedische Medizin eine weitverbreitete Behandlungsform bei Gonarthrose. Im Ayurveda kommen individualisierte Behandlungen mit multimodalem Konzept unter Miteinbeziehung von Manual- und Ern\u00e4hrungstherapie, Phytotherapie, Lebensstil-Beratung sowie Yoga-\u00dcbungen zum Einsatz [Tuffs 2002]. Jedoch liegen bislang noch keine klinischen Studien zur Behandlung von Gonarthrose mit Ayurveda durch einen solchen Ansatz vor [Hegana 2016]. Ziel dieser Arbeit war es, die klinische Wirksamkeit eines ayurvedischen Therapie-verfahrens am Beispiel der Gonarthrose zu \u00fcberpr\u00fcfen. Hierbei wurde ein Vergleich der beiden Behandlungsmethoden Ayurveda und konventionelle Therapie bei Gonarthrose vorgenommen. Hierzu wurden Probanden mit diagnostizierter Gonarthrose gem\u00e4\u00df der ACR-Kriterien (American College of Rheumatology) in eine \"multizentrische, rando-misierte, kontrollierte klinische Studie eingeschlossen.\" Von 151 Patienten erhielten 77 ausschlie\u00dflich eine Ayurveda-Behandlung und 74 eine konventionelle Behandlung. Dabei erhielten die Patienten \u00fcber einen Behandlungszeitraum von 12 Wochen jeweils 15 Therapiesitzungen. Der Prim\u00e4rzielparameter stellte der Western Ontario und McMaster University Osteoarthritis Index (WOMAC Index) in der validierten deutschen Version dar. Die \u00c4nderungen des WOMAC Index wurden \u00fcber einen Zeitraum von 12 Wochen beobachtet. Zu den sekund\u00e4ren Zielparametern geh\u00f6rten die WOMAC-Subskalen (Schmerz, Steifigkeit, Funktion); validierte Frageb\u00f6gen f\u00fcr Schmerz, Schmerzerfahrung, Lebensqualit\u00e4t und Stimmung; numerische Ratingskalen f\u00fcr Schmerz und Schlafqualit\u00e4t sowie Bedarfsmedikationsgebrauch und Sicherheitsaspekte. [Kessler 2018] Zusammenfassend l\u00e4sst sich feststellen, dass die \u00c4nderungen im WOMAC Index zwischen Ausgangswerten und dem Ergebnis nach 12 Wochen in der Ayurveda Gruppe signifikant st\u00e4rker ausgepr\u00e4gt waren (Mittelwertdifferenz 61,0 [95 % CI 52,4; 69,6]) als in der konventionellen Gruppe (32,0 [95 % CI 21,4;42,6]). Des Weiteren lie\u00dfen sich signifikante Unterschiede zwischen den beiden Gruppen (p < 0,001) und der klinisch relevanten Effektgr\u00f6\u00dfe (Cohens d 0,68 [95 % CI 0,35; 1,01]) feststellen. Auch f\u00fcr viele sekund\u00e4re Zielparameter konnten \u00e4hnliche Tendenzen zu Gunsten des Ayurveda beobachtet werden. Dar\u00fcber hinaus waren Effekte noch 3 und 9 Monaten nach der letzten Behandlung nachweisbar. Die Ergebnisse deuten darauf hin, dass die Behand-lung der Gonarthrose mittels einer komplexen Ayurveda-Therapie im Vergleich zur komplexen konventionellen Therapie wom\u00f6glich \u00fcberlegen sein k\u00f6nnte. Jedoch sind zun\u00e4chst weiterf\u00fchrende Studien erforderlich, um die Wirksamkeit zu belegen und um die Einfl\u00fcsse der verschiedenen Behandlungskomponenten sowie die Einfl\u00fcsse der nicht-spezifische Effekte weiter zu kl\u00e4ren. [Kessler 2018]", "language": null, "image": null, "pagetype": null, "links": ["https://www.fu-berlin.de/", "https://www.fu-berlin.de/", "/login", "https://www.fu-berlin.de/sites/refubium", "/contact", "https://www.fu-berlin.de/sites/refubium/ueber-uns/impressum", "https://www.fu-berlin.de/sites/refubium/ueber-uns/datenschutz/", "https://refubium.fu-berlin.de:443/handle/fub188/32464?locale-attribute=en", "#", "/login", "/", "/discover", "#", "#", "/community-list", "/browse?type=author", "/browse?type=subjectDDC", "/browse?type=affiliation", "/browse?type=doctype", "/browse?type=subject", "/browse?type=title", "#", "/handle/fub188/13/browse?type=author", "/handle/fub188/13/browse?type=subjectDDC", "/handle/fub188/13/browse?type=affiliation", "/handle/fub188/13/browse?type=doctype", "/handle/fub188/13/browse?type=subject", "/handle/fub188/13/browse?type=title", "#", "/login", "/register", "/handle/fub188/32464/statistics", "/", "/handle/fub188/1", "/handle/fub188/13", "https://refubium.fu-berlin.de/handle/fub188/32464", "http://dx.doi.org/10.17169/refubium-32189", "http://nbn-resolving.de/urn:nbn:de:kobv:188-refubium-32464-7", "/handle/fub188/32464?show=full", "/handle/fub188/13", "/bitstream/handle/fub188/32464/diss_m.spoo.pdf?sequence=1&isAllowed=y", "/bitstream/handle/fub188/32464/diss_m.spoo.pdf?sequence=1&isAllowed=y", "/bitstream/handle/fub188/32464/diss_m.spoo.pdf?sequence=1&isAllowed=y&save=y", "http://www.fu-berlin.de/sites/refubium/rechtliches/Nutzungsbedingungen", "/export/handle/fub188/32464/excel", "/export/handle/fub188/32464/csv", "/export/handle/fub188/32464/bibtex", "/contact", "https://www.fu-berlin.de/sites/refubium/ueber-uns/impressum", "https://www.fu-berlin.de/sites/refubium/ueber-uns/datenschutz/", "javascript:window.print()", "/feedback", "https://www.fu-berlin.de/sites/refubium", "http://www.dini.de/dini-zertifikat/", "#"]}